The orbital inflammatory diseases require a comprehensive treatment plan for their diagnosis and cure. The options for treatment of ophthalmic diseases has increased with the increased availability of biologically targeted agents that act on a specific segment of the inflammatory cascade. The treatment requires real-time immunologic monitoring of the disease to find out future directions for targeted therapy of the diseases.
Related Journals: Journal of Lasers, Optics & Photonics, Neuro-Ophthalmology, Progress in Retinal and Eye Research, Journal of Glaucoma, Ophthalmic Genetics.